Ulrik Gether
University of Copenhagen · 293 works · 17,905 citations · h-index 71
Top works
- Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
- G Protein-coupled Receptors
- Correlation between Genetic and Geographic Structure in Europe
- [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.
- Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6
- Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor
- Structural Instability of a Constitutively Active G Protein-coupled Receptor
- Fluorescent Labeling of Purified β2 Adrenergic Receptor
- Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist
- Validity of the diagnosis of a single depressive episode in a case register
- A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
- SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
- Maltose–neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins
- Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase
- Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
- Mutation of a Highly Conserved Aspartic Acid in the β2Adrenergic Receptor: Constitutive Activation, Structural Instability, and Conformational Rearrangement of Transmembrane Segment 6
- How curved membranes recruit amphipathic helices and protein anchoring motifs
- Agonist-induced Conformational Changes at the Cytoplasmic Side of Transmembrane Segment 6 in the β2 Adrenergic Receptor Mapped by Site-selective Fluorescent Labeling
- The binding sites for cocaine and dopamine in the dopamine transporter overlap
- Neurotransmitter transporters: molecular function of important drug targets